A Phase Ia/Ib, Open-Label, Multicenter, Global, Dose- Escalation Study to Evaluate the Safety and Pharmacokinetics of XmAb24306 as a Single Agent and in Combination with Atezolizumab in Patients with Locally Advanced or Metastatic Solid Tumors.

  • Haydon, Andrew (Primary Chief Investigator (PCI))
  • Brooks, Christine (Project Manager)

Project: Research

Project Details

Effective start/end date1/09/2131/12/26


  • Medical oncology
  • Clinical trial